If PV/LPV in RAD51C and BRIP1 genes, besides BRCA genes, are also considered as potentially actionable for treatment with PARP inhibitors, then a total of 42 potentially actionable PV/LPV were detected by tumor or germline genotyping. Here, BRIP1 is linked to neoplasm.